Drug targets identified through cell line to potentially treat rare pediatric cancer

A team of investigators has made key new findings about an extremely rare childhood cancer called neurocutaneous melanocytosis. This malignant cancer is characterized by an excessive growth of melanin-producing cells in both the skin and the brain. The study’s authors found potential drug targets for the disease by using a molecular analysis of patient tumor cells grown in animal models. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *